Results 101 to 110 of about 266,324 (188)

Podocyte Lipotoxicity in CKD. [PDF]

open access: yesKidney360, 2021
Kim JJ, Wilbon SS, Fornoni A.
europepmc   +1 more source

High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells [PDF]

open access: yes, 2022
Annalisa Ronca   +3 more
core   +1 more source

Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin [PDF]

open access: yes, 2017
The present study is the first intervention study in a well-established, translational mouse model for hyperlipidaemia and atherosclerosis showing that anacetrapib dose-dependently reduces atherosclerosis development and adds to the anti-atherogenic ...
Havekes, Louis M.   +12 more
core  

Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol. [PDF]

open access: yesJ Atheroscler Thromb, 2022
Hirano T   +11 more
europepmc   +1 more source

The Interdependency and Co-Regulation of the Vitamin D and Cholesterol Metabolism. [PDF]

open access: yesCells, 2021
Warren T   +11 more
europepmc   +1 more source

Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock-A Prospective Pilot Study. [PDF]

open access: yesFront Med (Lausanne), 2020
Reisinger AC   +10 more
europepmc   +1 more source

High Polyphenol Extra Virgin Olive Oil and Metabolically Unhealthy Obesity: A Scoping Review of Preclinical Data and Clinical Trials. [PDF]

open access: yesClin Pract
Liva K   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy